Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

CHina Adrenal Venous saMPling InvestigatiON (CHAMPION)

6 novembre 2026 mis à jour par: Hui DONG, Chinese Academy of Medical Sciences, Fuwai Hospital

Enquête nationale chinoise sur l'échantillonnage veineux surrénalien : une étude multicentrique nationale

Primary aldosteronism (PA) is a major cause of secondary hypertension, yet its optimal diagnosis and management remain challenging. This study comprehensively evaluates adrenal venous sampling (AVS), addressing key clinical, technical, and methodological issues, and aims to clarify the relationship between AVS-guided management and long-term clinical and biochemical outcomes to optimize patient care and prognosis.

Aperçu de l'étude

Description détaillée

Primary aldosteronism (PA) is one of the most common causes of secondary hypertension, yet its optimal diagnostic and therapeutic strategies remain challenging. Adrenal venous sampling (AVS) is regarded as the gold standard for subtype differentiation; however, important clinical, technical, and methodological issues have not been systematically addressed. This study is designed to comprehensively evaluate AVS and its clinical implications, aiming to elucidate the relationship between AVS-guided diagnosis and management of PA and long-term clinical and biochemical outcomes, while refining AVS protocols, standardizing clinical practice, optimizing therapeutic decision-making, and ultimately improving patient management and prognosis.

Type d'étude

Observationnel

Inscription (Estimé)

5000

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Sauvegarde des contacts de l'étude

Lieux d'étude

    • Anhui
      • Hefei, Anhui, Chine, 230036
        • Recrutement
        • The first affiliated hospital of USTC
        • Contact:
        • Chercheur principal:
          • Xiangyong Kong, PhD
    • Beijing Municipality
      • Beijing, Beijing Municipality, Chine, 100034
        • Recrutement
        • Peking University First Hospital
        • Chercheur principal:
          • Wei Ma, MD
        • Contact:
      • Beijing, Beijing Municipality, Chine, 100044
        • Recrutement
        • Peking University People's Hospital
        • Contact:
        • Chercheur principal:
          • Jing Liu, MD
      • Beijing, Beijing Municipality, Chine, 100029
        • Recrutement
        • China-Japan Friendship Hospital
        • Chercheur principal:
          • Wuqiang Che, MD
        • Contact:
      • Beijing, Beijing Municipality, Chine, 100022
        • Recrutement
        • Chuiyangliu Hospital affiliated to Tsinghua University
        • Chercheur principal:
          • Lin Pi, MD
        • Contact:
      • Beijing, Beijing Municipality, Chine, 100037
        • Recrutement
        • Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College
        • Chercheur principal:
          • Hui Dong, MD
        • Contact:
        • Contact:
      • Beijing, Beijing Municipality, Chine, 101100
        • Recrutement
        • Beijing Luhe Hospital, Capital Medical University
        • Contact:
        • Chercheur principal:
          • Dong Zhao, MD, PhD
    • Chongqing Municipality
      • Chongqing, Chongqing Municipality, Chine, 400000
        • Recrutement
        • Chongqing University Central Hospital
        • Chercheur principal:
          • Dongying Zhang, MD
        • Contact:
      • Chongqing, Chongqing Municipality, Chine, 401147
        • Recrutement
        • Chongqing General Hospital
        • Chercheur principal:
          • Rui He, MM
        • Contact:
      • Chongqing, Chongqing Municipality, Chine, 404100
        • Recrutement
        • People's Hospital Affiliated to ChongqingThree Gorges Medical college
        • Chercheur principal:
          • Xianhu Luo, MD
        • Contact:
    • Fujian
      • Fuzhou, Fujian, Chine, 0591-87982222
        • Recrutement
        • First Affiliated Hospital, Fujian Medical University, Fuzhou, China,
        • Contact:
        • Chercheur principal:
          • Feng Peng, MD
      • Xiamen, Fujian, Chine, 361016
        • Recrutement
        • Cardiovascular Hospital Xiamen University
        • Chercheur principal:
          • Tao Ye, MD
        • Contact:
    • Gansu
      • Lanzhou, Gansu, Chine, 730000
        • Recrutement
        • Lanzhou University Second Hospital
        • Chercheur principal:
          • Wei Liang, MD
        • Contact:
    • Guangdong
      • Foshan, Guangdong, Chine, 528211
        • Recrutement
        • The Forth People's Hosptal of Nanhai District of Foshan City
        • Chercheur principal:
          • Yayan Han, MD
        • Contact:
      • Guangzhou, Guangdong, Chine, 510080
        • Recrutement
        • Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences)
        • Chercheur principal:
          • Yingqing Feng, MD
        • Contact:
          • Yingqing Feng, MD
          • Numéro de téléphone: 13602863389
          • E-mail: fyq1819@163.com
      • Shenzhen, Guangdong, Chine, 518000
        • Recrutement
        • Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen
        • Contact:
        • Chercheur principal:
          • Jianqiong Kong, MD
      • Shenzhen, Guangdong, Chine, 518112
        • Recrutement
        • Shenzhen Third People's Hospital,Shenzhen, Guangdong Province 518112, China
        • Contact:
          • Zhenzhong Zheng, MD, PhD
          • Numéro de téléphone: 0755-61222333
          • E-mail: greateful@163.com
        • Chercheur principal:
          • Zhenzhong Zheng, MD, PhD
      • Shenzhen, Guangdong, Chine, 518116
        • Recrutement
        • Shenzhen Dapeng New District Kuiyong People's Hospital
        • Chercheur principal:
          • Tongqing Lu, MD
        • Contact:
    • Guangxi
      • Nanning, Guangxi, Chine, 530000
        • Recrutement
        • The First Affiliated Hospital of Guangxi Medical University
        • Chercheur principal:
          • Jiangnan Huang, MD
        • Contact:
      • Nanning, Guangxi, Chine, 530007
        • Recrutement
        • The Second Affliated Hospital Of GuangXi Medical Univesity
        • Contact:
        • Chercheur principal:
          • Houfa Ning, MM
      • Nanning, Guangxi, Chine, 547000
        • Recrutement
        • Nanning Third People's Hospital
        • Contact:
          • Yongqi Xiao, MBBS
          • Numéro de téléphone: 07713394390
        • Chercheur principal:
          • Yongqi Xiao, MBBS
    • Guizhou
      • Guiyang, Guizhou, Chine, 550004
        • Recrutement
        • The Affiliated Hospital of Guizhou Medical University
        • Contact:
        • Chercheur principal:
          • Zhangrong Chen, MD
      • Guiyang, Guizhou, Chine, 550002
        • Recrutement
        • Guizhou Provincial People's Hospital, Guiyang, Guizhou 550002, China.
        • Contact:
        • Chercheur principal:
          • Fang Song, MD
      • Kaili, Guizhou, Chine, 556000
        • Recrutement
        • The Second Affiliated Hospital Of Guizhou Medical University
        • Chercheur principal:
          • Yumei Xiang, MD
        • Contact:
    • Hainan
      • Haikou, Hainan, Chine, 570311
        • Recrutement
        • Hainan General Hospital, Department of Endocrinology
        • Contact:
        • Chercheur principal:
          • Haiyu Zhang, MM
      • Hainan, Hainan, Chine, 570311
        • Recrutement
        • Hainan General Hospital, Department of Cardiology
        • Contact:
        • Chercheur principal:
          • Wang Liao, MD
    • Hebei
      • Tangshan, Hebei, Chine, 063000
        • Recrutement
        • Tangshan hongci Hospital
        • Chercheur principal:
          • Guijuan Zhang, MD
        • Contact:
    • Heilongjiang
      • Harbin, Heilongjiang, Chine, 150086
        • Recrutement
        • The Second Affiliated Hospital of Harbin Medical University
        • Contact:
        • Chercheur principal:
          • Shuo Zhang, MD
      • Harbin, Heilongjiang, Chine, 150001
        • Recrutement
        • The First Affiliated Hospital of Harbin Medical University
        • Chercheur principal:
          • Dechao Zhao, MD
        • Contact:
    • Henan
      • Kaifeng, Henan, Chine, 475002
        • Recrutement
        • Kai Feng the Peoples Hospital
        • Contact:
        • Chercheur principal:
          • Qingli Pan, MD
      • Zhengzhou, Henan, Chine, 450052
        • Recrutement
        • The First Affiliated Hospital of Zhengzhou University
        • Contact:
        • Chercheur principal:
          • Youyou Du, MD
      • Zhengzhou, Henan, Chine, 450003
        • Recrutement
        • Henan Provincial People's Hospital
        • Chercheur principal:
          • Min Liu, MD
        • Contact:
      • Zhengzhou, Henan, Chine, 450000
        • Recrutement
        • Fuwai Central China Cardiovascular Hospital
        • Chercheur principal:
          • Qiuping Zhao, PhD
        • Contact:
      • Zhengzhou, Henan, Chine, 450018
        • Recrutement
        • Zhengzhou Yihe Hospital
        • Contact:
        • Chercheur principal:
          • Liang An, MD
      • Zhengzhou, Henan, Chine, 450007
        • Recrutement
        • Zhengzhou Central Hospital Affiliated to Zhengzhou University
        • Chercheur principal:
          • Shuhua Yu, MM
        • Contact:
      • Zhoukou, Henan, Chine, 466000
        • Recrutement
        • Zhoukou Central Hospital
        • Chercheur principal:
          • Baogong Wang, MD
        • Contact:
          • Baogong Wang, MD
          • Numéro de téléphone: 0394-8521613
          • E-mail: 598634874@qq.com
    • Hubei
      • Wuhan, Hubei, Chine, 430060
        • Recrutement
        • Renmin Hospital of Wuhan University
        • Contact:
        • Chercheur principal:
          • Hongxin Xu, MD
      • Xiangyang, Hubei, Chine, 441021
        • Recrutement
        • Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science
        • Contact:
        • Chercheur principal:
          • Qingan Li, MD
      • Yichang, Hubei, Chine, 43000
        • Recrutement
        • Yichang Central People's Hospital
        • Chercheur principal:
          • Yunbo Lv, MD
        • Contact:
    • Hunan
      • Zhuzhou, Hunan, Chine, 412000
        • Recrutement
        • Zhuzhou Hospital Affiliated to Xiangya School of Medicine,Central South University
        • Contact:
          • Liang Tang, MBBS
          • Numéro de téléphone: 0733-28561703
        • Chercheur principal:
          • Liang Tang, MBBS
    • Jiangsu
      • Xuzhou, Jiangsu, Chine, 221009
        • Recrutement
        • Xuzhou Central Hospital, Jiangsu
        • Contact:
        • Chercheur principal:
          • Hongyun Ruan, MD
    • Jiangxi
      • Ganzhou, Jiangxi, Chine, 341000
        • Recrutement
        • The First Affiliated Hospital of Gannan Medical University
        • Contact:
          • Jiayuan Ling, MD
          • Numéro de téléphone: 18807972012
          • E-mail: 15803152@qq.com
        • Chercheur principal:
          • Jiayuan Yuan, MD
      • Nanchang, Jiangxi, Chine, 330006
        • Recrutement
        • Second Affiliated Hospital of Nanchang University
        • Contact:
          • Yifei Dong, MD, PhD
          • Numéro de téléphone: 0791-8735-7354
          • E-mail: yf_dong66@126.com
        • Chercheur principal:
          • Yifei Dong, MD, PhD
      • Nanchang, Jiangxi, Chine, 330038
        • Recrutement
        • Jiangxi Provincial People's Hospital (The First Affiliated Hospital of Nanchang Medical College)
        • Chercheur principal:
          • Haohang Ruan, MBBS
        • Contact:
          • Haohang Ruan, MBBS
          • Numéro de téléphone: 0791-87721036
    • Jilin
      • Changchun, Jilin, Chine, 130021
        • Recrutement
        • The First Hospital of Jilin University
        • Contact:
        • Chercheur principal:
          • Wei Zhao, MD
      • Changchun, Jilin, Chine, 130051
        • Recrutement
        • Jilin Province FAW General Hospital
        • Chercheur principal:
          • Wenhai Wang, MM
        • Contact:
    • Liaoning
      • Dalian, Liaoning, Chine, 116001
        • Recrutement
        • Affilated Zhongshan Hospital of Dalian University
        • Contact:
        • Chercheur principal:
          • Minglian Gong, MD
      • Dalian, Liaoning, Chine, 116011
        • Recrutement
        • Frist Aiffiliated Hospital of Dalian Medical University
        • Chercheur principal:
          • Yinong Jiang, MD
        • Contact:
      • Dalian, Liaoning, Chine, 116027
        • Recrutement
        • The second hospital of Dalian Medical University
        • Contact:
        • Chercheur principal:
          • Nan Niu, MD
    • Neimenggu
      • Ulanhot, Neimenggu, Chine, 137400
        • Recrutement
        • Inner Mongolia Xing'an League People's Hospital
        • Contact:
        • Chercheur principal:
          • Tao Guo, MM
    • Ningxia
      • Yinchuan, Ningxia, Chine, 750000
        • Recrutement
        • The First People's Hospital of Yinchuan
        • Contact:
        • Chercheur principal:
          • Fang Chen, PhD
    • Qinghai
      • Xining, Qinghai, Chine, 810001
        • Recrutement
        • Qinghai University Affiliated Hospital
        • Contact:
        • Chercheur principal:
          • Ming Ren, MM
      • Xining, Qinghai, Chine, 810000
        • Recrutement
        • Qinghai Province Cardiovascular and Cerebrovascular Disease Specialist Hospital
        • Contact:
          • Xiaozhou Wang, MD
          • Numéro de téléphone: 0971-6288407
          • E-mail: wxz_1978@163.com
        • Chercheur principal:
          • Xiaozhou Wang, MD
    • Shandong
      • Jinan, Shandong, Chine, 250012
        • Recrutement
        • Qilu Hospital of Shandong University
        • Chercheur principal:
          • Peili Bu, MD
        • Contact:
      • Jinan, Shandong, Chine, 250013
        • Recrutement
        • Central Hospital Affiliated to Shandong First Medical University
        • Contact:
        • Chercheur principal:
          • Rui Xu, MD, PhD
      • Jinan, Shandong, Chine, 250000
        • Recrutement
        • the Second Hospital, Cheeloo College of Medicine, Shandong University
        • Contact:
        • Chercheur principal:
          • Qinghai Wang, MD
      • Liaocheng, Shandong, Chine, 252200
        • Recrutement
        • People's Hospital of Donga County, Shandong Province
        • Chercheur principal:
          • Xiaoli Wang, MD
        • Contact:
      • Qingdao, Shandong, Chine, 266000
        • Recrutement
        • Qingdao Hospital University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital)
        • Contact:
        • Chercheur principal:
          • Nan Jia, MD
    • Shanghai Municipality
      • Shanghai, Shanghai Municipality, Chine, 200025
        • Recrutement
        • Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine
        • Contact:
        • Chercheur principal:
          • Jianzhong Xu, MD, PhD
      • Shanghai, Shanghai Municipality, Chine, 200062
        • Recrutement
        • Shanghai Putuo District Central Hospital
        • Chercheur principal:
          • Zongjun Liu, MD
        • Contact:
      • Shanghai, Shanghai Municipality, Chine, 200080
        • Recrutement
        • Shanghai General Hospital ( originally named Shanghai First People's Hospital), Shanghai Jiao Tong University School of Medicine
        • Contact:
          • Zhi Zhang, MD
          • Numéro de téléphone: 13621759762
          • E-mail: 16683890@qq.com
        • Chercheur principal:
          • Zhi Zhang, MD
    • Shanxi
      • Taiyuan, Shanxi, Chine, 030001
        • Recrutement
        • the second hospital of ShanXi medical unversity
        • Chercheur principal:
          • Bin Yang, MD
        • Contact:
      • Xi’an, Shanxi, Chine, 710018
        • Recrutement
        • Xi'an People's Hospital
        • Contact:
        • Chercheur principal:
          • Kang Cheng, MD, PhD
    • Sichuan
      • Chengdu, Sichuan, Chine, 611130
        • Recrutement
        • Chengdu Fifth People's Hospital
        • Chercheur principal:
          • Mingjian Lang, MD
        • Contact:
          • Mingjian Lang
          • Numéro de téléphone: (028) 8271 0681
          • E-mail: zcl628@163.com
      • Chengdu, Sichuan, Chine, 610500
        • Recrutement
        • The First Affiliated Hospital of Chengdu Medical College
        • Chercheur principal:
          • Peijian Wang, MD
        • Contact:
      • Chengdu, Sichuan, Chine, 610031
        • Recrutement
        • The Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chengdu, China
        • Chercheur principal:
          • Zhen Zhang, MD
        • Contact:
          • Zhen Zhang, MD
          • Numéro de téléphone: 13708042927
          • E-mail: 31350377@qq.com
    • Tianjin Municipality
      • Tianjin, Tianjin Municipality, Chine, 300052
        • Recrutement
        • Tianjin Medical University General Hospital
        • Chercheur principal:
          • Dianxun Fu, MD
        • Contact:
      • Tianjin, Tianjin Municipality, Chine, 300211
        • Recrutement
        • The Second Hospital of Tianjin Medical University
        • Chercheur principal:
          • Changle Liu, MD
        • Contact:
      • Tianjin, Tianjin Municipality, Chine, 300457
        • Recrutement
        • TEDA International Cardiovascular Hospital
        • Contact:
        • Chercheur principal:
          • Weiqiang Wang, MM
    • Tibet
      • Chamdo, Tibet, Chine, 854000
        • Recrutement
        • Changdu People's Hospital of Tibet
        • Contact:
          • Rui Xiang, MD
          • Numéro de téléphone: 0895-4821745
        • Chercheur principal:
          • Rui Xiang, MD
    • Xinjiang
      • Yining, Xinjiang, Chine, 835000
        • Recrutement
        • Yili Kazak Autonomous Prefecture Friendship Hospital
        • Contact:
        • Chercheur principal:
          • Wei Li, MBBS
      • Ürümqi, Xinjiang, Chine, 830001
        • Recrutement
        • Xinjiang Uygur Autonomous Region People's Hospital
        • Contact:
          • Guoliang Wang, PhD
          • Numéro de téléphone: 0991-8563065
          • E-mail: 908022751@qq.com
        • Chercheur principal:
          • Guoliang Wang, PhD
    • Yunnan
      • Kunming, Yunnan, Chine, 650031
        • Recrutement
        • The First Affiliated Hospital of Kunming Medical University
        • Contact:
        • Chercheur principal:
          • Lihua Zhang, PhD
      • Kunming, Yunnan, Chine, 650102
        • Recrutement
        • Fuwai Yunnan Cardiovascular Hospital
        • Chercheur principal:
          • Zihong Guo, MD
        • Contact:
      • Kunming, Yunnan, Chine, 650051
        • Recrutement
        • Yan'an Affiliated Hospital of Kunming Medical University
        • Contact:
        • Chercheur principal:
          • Yan He, MD
    • Zhejiang
      • Hangzhou, Zhejiang, Chine, 310000
        • Recrutement
        • Zhejiang Hospital
        • Chercheur principal:
          • Yimin Tang, MD
        • Contact:

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans et plus (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

Méthode d'échantillonnage

Échantillon non probabiliste

Population étudiée

All patients with confirmed primary aldosteronism underwent adrenal venous sampling.

La description

Inclusion Criteria:

  1. Patients with confirmed primary aldosteronism;
  2. Patients undergoing adrenal venous sampling for subtype classification of primary aldosteronism.

Exclusion Criteria:

  1. Severe comorbidity, including stroke, myocardial infarction, heart failure, severe valvular heart disease, liver cirrhosis, and metastatic tumor within the previous 3 months;
  2. An estimated glomerular filtration rate <45 ml/min/1.73 m2, or serum creatinine >176 μmol/L;
  3. Patients who refuse adrenalectomy;
  4. Suspected of having an adrenocortical carcinoma;
  5. Allergy to contrast agent;
  6. Pregnant, nursing, or planning to become pregnant

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Modèles d'observation: COHORT
  • Perspectives temporelles: OTHER

Cohortes et interventions

Groupe / Cohorte
Intervention / Traitement
Adrenal Venous Sampling

Patients with Primary Aldosteronism (PA) undergoing Adrenal Venous Sampling via antecubital approach or femoral approach to discriminate PA forms with unilateral from bilateral excess aldosterone production.

Patients with Primary Aldosteronism (PA) undergoing Adrenal Venous Sampling via antecubital approach or femoral approach to discriminate PA forms with unilateral from bilateral excess aldosterone production.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Major adverse cardiovascular events (MACE) at 1-year follow-up
Délai: 1 year after AVS procedure

Incidence of major adverse cardiovascular events (MACE) at 1-year follow-up, including stroke, heart failure, severe arrhythmias, renal failure, myocardial infarction, and death.

1 year after AVS procedure

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
The success rate of left adrenal venous sampling
Délai: At AVS procedure

Successful sampling will be defined by high selectivity index (cortisol in the adrenal vein/cortisol in inferior vena cava >2 without ACTH simulation)

At AVS procedure
The success rate of right adrenal venous sampling
Délai: At AVS procedure

Successful sampling will be defined by high selectivity index (cortisol in the adrenal vein/cortisol in inferior vena cava >2 without ACTH simulation)

At AVS procedure
The success rate of bilateral adrenal venous sampling
Délai: At AVS procedure

Successful sampling will be defined by high selectivity index (cortisol in the adrenal vein/cortisol in inferior vena cava >2 without ACTH simulation)

At AVS procedure
Selection of intraoperative catheter
Délai: At AVS procedure

Types of catheter at the time of Adrenal Venous Sampling via antecubital approach or femoral approach

At AVS procedure
Time of the procedure
Délai: At AVS procedure

Time of the procedure

At AVS procedure
Time of fluoroscopy
Délai: At AVS procedure

Time of fluoroscopy

At AVS procedure
The contrast agent dosage
Délai: At AVS procedure

The contrast agent dosage

At AVS procedure
the incidence of complications
Délai: 1 week after AVS procedure

Complications related to adrenal vein cannulations (adrenal vein hematoma, inferior vena cava dissection, puncture site hematoma, etc)

1 week after AVS procedure
the cost of the procedure
Délai: At AVS procedure

the cost of the procedure

At AVS procedure
Change in 24-hour ambulatory systolic blood pressure
Délai: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment

The difference in average systolic blood pressure measured by 24-hour ambulatory blood pressure monitoring (ABPM) between baseline and each follow-up time point.

At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
Change in 24-hour ambulatory diastolic blood pressure
Délai: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment

The difference in average diastolic blood pressure measured by 24-hour ambulatory blood pressure monitoring (ABPM) bewteen baseline and each follow-up time point.

At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
Change in office systolic blood pressure
Délai: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment

The difference in systolic blood pressure measured during clinic visits (office blood pressure) between baseline and each follow-up time point

At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
Change in office diastolic blood pressure
Délai: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment

The difference in diastolic blood pressure measured during clinic visits (office blood pressure) between baseline and each follow-up time point

At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
Change in antihypertensive medication burden
Délai: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment

The change in the number and/or dosage of antihypertensive medications taken by patients between baseline and each follow-up time point

At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
Change in urinary albumin-to-creatinine ratio (UACR)
Délai: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment

The difference in urinary albumin-to-creatinine ratio measured at baseline and at each follow-up time point

At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
Change in left ventricular mass index (LVMI)
Délai: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment

The change in left ventricular mass index, as assessed by echocardiography, from baseline to each follow-up time point.

At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
Change in pulse wave velocity (PWV) from baseline
Délai: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment

The change in pulse wave velocity measured between baseline and each follow-up time point。

At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
Clinical Outcome According to Primary Aldosteronism Surgical Outcome (PASO) Criteria
Délai: At 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after surgery

Clinical outcomes will be assessed at each follow-up visit afteradrenal surgery according to the PASO consensus criteria. Outcomes will be categorized as:

(1)Complete clinical success: normal blood pressure without the need for any antihypertensive medication. (2)Partial clinical success: improvement in blood pressure and/or a reduction in the number or dosage of antihypertensive medications. (3)Absent clinical success: no improvement in blood pressure or antihypertensive medication burden.

At 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after surgery
Biochemical Outcome According to Primary Aldosteronism Surgical Outcome (PASO) Criteria
Délai: At 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after surgery

Biochemical outcomes will be assessed at each follow-up visit after adrenal surgery according to the PASO consensus classification. Outcomes will be categorized as:(1)Complete biochemical success: normal serum potassium levels and a normalized aldosterone-to-renin ratio (ARR) without the need for potassium supplementation.(2)Partial biochemical success: improvement in biochemical parameters without full normalization.(3)Absent biochemical success: no improvement in biochemical markers compared to baseline.

At 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after surgery
Major adverse cardiovascular events (MACE)
Délai: At 6 and 18 months; and 2, 3, 4, 5, and 10 years after AVS procedure

Incidence of major adverse cardiovascular events (MACE), including stroke, heart failure, severe arrhythmias, renal failure, myocardial infarction, and death.

At 6 and 18 months; and 2, 3, 4, 5, and 10 years after AVS procedure

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Hui Dong, MD, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

1 décembre 2025

Achèvement primaire (Estimé)

31 août 2029

Achèvement de l'étude (Estimé)

31 août 2029

Dates d'inscription aux études

Première soumission

19 novembre 2025

Première soumission répondant aux critères de contrôle qualité

19 novembre 2025

Première publication (Réel)

26 novembre 2025

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

10 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

6 novembre 2026

Dernière vérification

1 novembre 2026

Plus d'information

Termes liés à cette étude

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner